Elehear Beyond vs Otofonix Groove

The Elehear Beyond is a behind-the-ear OTC hearing aid priced at $431, earning an A grade with a SoundScore of 4.3/5. This places it in the top 11% of all OTC hearing aids tested, ranking #8 out of 65 devices in its category—a standout result for a budget-tier product. In our lab testing, the Beyond demonstrates particular strength in speech clarity for quiet environments, scoring 4.3/5—a full 1.48 points above the OTC category average. Music streaming quality is another highlight at 3.8/5, measuring 1.88 points above average and delivering solid fidelity for phone audio. Speech understanding in noisy situations scores 2.3/5, which is 0.83 points above the category average but remains mixed in absolute terms—a common limitation among OTC devices. Feedback handling is excellent at 4.5/5, providing stable performance during typical use. Own-voice comfort scores 2.6/5, slightly above the category average but still in mixed territory, which may be noticeable for some users during conversation. The Beyond earned a 2024 Expert's Choice Award and represents strong value in the budget OTC segment. It outperforms several same-price competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni. This device is best suited for those seeking reliable speech clarity in quieter settings and quality streaming audio without the higher cost of prescription alternatives.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.